Clinical Study on the Early Bactericidal Activity of Contezolid Against Mycobacterium Abscessus Disease

NCT07372781 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Monotherapy
Mycobacterium Abscessus Infection

Interventions

DRUG: Contezolid
DRUG: linezolid

Sponsor

Beijing Chest Hospital